Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Supplementary Methods, Table 1, Figures 1-9 from Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
Home
Publications
Supplementary Methods, Table 1, Figures 1-9 from Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
Supplementary Methods, Table 1, Figures 1-9 from Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
JG
James G. Greger
James G. Greger
SE
Stephen D. Eastman
Stephen D. Eastman
VZ
Vivian Zhang
Vivian Zhang
MB
Maureen R. Bleam
Maureen R. Bleam
AH
Ashley M. Hughes
Ashley M. Hughes
KS
Kimberly N. Smitheman
Kimberly N. Smitheman
SD
Scott H. Dickerson
Scott H. Dickerson
SL
Sylvie G. Laquerre
Sylvie G. Laquerre
LL
Li Liu
Li Liu
TG
Tona M. Gilmer
Tona M. Gilmer
Open Access
Publisher Website
Google Scholar
Cite
Download
Share
Download
3 April 2023
other
Published by
American Association for Cancer Research (AACR)
https://doi.org/10.1158/1535-7163.22499103.v1
Abstract
No abstract available